Multiple ileal perforations due to regular diclofenac sodium injections: a case report by Won Park et al.
Park et al. BMC Research Notes 2013, 6:129
http://www.biomedcentral.com/1756-0500/6/129CASE REPORT Open AccessMultiple ileal perforations due to regular
diclofenac sodium injections: a case report
Won Seok Park1, Sang Wook Kim3*, Seok Lee2, Soo Teik Lee3 and Ho Sung Park4Abstract
Background: Although the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) on the upper
gastrointestinal tract have been well characterized, those specific to the lower gastrointestinal tract are less clear, as
only a limited number of articles and case reports exist in the literature.
Case presentation: We describe a case of a 69-year-old woman who presented to the emergency department due
to sudden onset abdominal distension and pain. Notably, she reported using intramuscular diclofenac sodium twice
daily for 14 days after knee joint replacement surgery. The patient denied any other coexisting diseases. As a
subsequent X-ray and computed tomography (CT) scan showed free air in the abdomen, an exploratory
laparotomy was performed, revealing four free perforations in the terminal ileum. Findings on microscopic analysis
were non-specific.
Conclusion: We report a unique case of multiple ileal perforations due to regular diclofenac sodium injections and
contend that ileal perforation can be considered as a source for pneumoperitoneum with concomitant peritonitis
in patients with a history of NSAID use if other possibilities are excluded.
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Non-steroidal anti-inflammatory drugs (NSAIDs) – in-
cluding aspirin – have a long history of clinical use given
their potent antipyretic, analgesic, and anti-inflammatory
effects. However, NSAIDs also have a well-described ser-
ious side effect profile, most notably including gastro-
intestinal injury. With 7.9% of the Korean population
considered elderly [1], NSAID use continues to increase,
with NSAID-related gastrointestinal injury now a com-
mon clinical problem [2].
As capsule endoscopy and balloon enteroscopy are now
able to detect even the smallest of small intestinal lesions,
NSAID-induced enteropathy has become a topic of great
interest in the gastroenterology literature. Moreover, new
data now suggest that the prevalence of NSAID-induced
enteropathy is higher than previously expected, and is likely
continuing to increase [3]. Although the gross appearance* Correspondence: clickm@jbnu.ac.kr
3Departments of Internal Medicine and Research Institute for Medical
Science, Chonbuk National University College of Medicine, Geumam 2-dong,
Deokjin-gu, Jeonju 561-712, Republic of Korea
Full list of author information is available at the end of the article
© 2013 Park et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordiaphragm-like strictures, ulcers, erosions, and mucosal
redness – few case reports of NSAID-induced ileal perfor-
ation exist. Herein, we report a case of multiple ileal perfo-
rations secondary to diclofenac use.Case presentation
A 69-year-old woman presented to the emergency de-
partment with sudden onset abdominal distension and
mild abdominal pain though denied diarrhea or fever.
Notably, she reported that she had been using intramus-
cular diclofenac sodium twice a day for the past 14 days
due to pain stemming from a recent knee joint replace-
ment surgery. The patient denied any other coexisting
diseases.
Physical examination revealed a distended abdomen
with slight tenderness in the right lower quadrant. Al-
though all laboratory tests – including the Widal test –
were normal, a simple chest X-ray showed free air in the
abdomen. A computed tomography scan of the abdomen
was then performed, showing a large fluid collection and
pneumoperitoneum, though no definite mass or site of
perforation could be identified.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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laparotomy, revealing multiple mucosal defects in the
terminal ileum, including a total of four discrete perfora-
tions, each approximately 5 mm in size. However, a sub-
sequent microscopic analysis did not reveal any specific
findings around the sites of perforation, such as inflamma-
tory cell infiltrates with thrombi, malignancies, or findings
suggestive of inflammatory bowel disease (Figure 1). Ac-
cordingly, a diagnosis of multiple ileal perforations sec-
ondary to diclofenac use was reached, as the patient had
no specific past medical history and the relevant labora-
tory testing and histopathology did not suggest any other
underlying etiology. After surgery, the patient had an un-
remarkable course of recovery, and was followed as an
outpatient without any additional complications.
Discussion
NSAIDs have a well-characterized adverse event profile,
including many upper gastrointestinal tract-related com-
plications. These side effects clearly contribute signifi-
cantly to the morbidity and mortality of individuals
treated with this class of medications. However, NSAIDs
are also capable of producing similar complications in
the lower gastrointestinal tract, including the jejunum
and ileum, and it is generally well accepted that NSAID-
induced gastrointestinal injury occurs more frequently in
the small bowel than in the stomach [4].
Though the incidence of NSAID-induced enteropathy
is believed to be higher than previously expected, the
exact rate has never been determined. According to one
study including the post-mortem results of 713 patients
both with and without a history of NSAID use, nonspecific
small-intestinal ulcerations were found in 21 (8.4%) of
NSAID users and 3 (0.6%) nonusers. Additionally, three
long-term NSAID users were found to have died from
complications arising from perforated nonspecific small-
intestinal ulcers [5]. Another similar study also reported
that after enteroscopy, jejunal or ileal ulcerations wereFigure 1 Histopathology showing nonspecific inflammation and exclu
(A) reveals an ulcer with perforation (H&E, x20). The high power view (B) reve
neutrophils) and granulation tissue formation at the perforated ileal wall (H&Edetected in 47% of patients treated with NSAIDs for
rheumatoid arthritis [6].
Prostaglandin is critically involved in regulating the
gastrointestinal blood flow as well as other various mu-
cosal functions. As such, the NSAID-induced decrease
in prostaglandin production is believed to represent the
primary cause of small bowel injuries due to NSAID use.
Specifically, NSAIDs decrease endogenous mucosal
prostaglandins, which results in decreased amounts of
intestinal mucus, other microcirculatory disturbances
secondary to pharmacologically increased intestinal mo-
tility, intercellular junction disruption, and increased
mucosal permeability. The subsequent mucosal injuries
can occur secondary to damage caused by bile acid, pro-
teolytic enzymes, intestinal bacteria, or other toxins.
Moreover, all of these processes induce inflammatory
cytokine production as well as neutrophil infiltration,
with the lipopolysaccharide/toll-like receptor 4 pathway
also playing an important role in the etiology of such
mucosal injuries [7].
The most basic principle in the treatment of NSAID-
induced injuries is to discontinue all NSAID use. How-
ever, often only a temporary cessation of NSAID use is
possible, as many patients require NSAIDs daily for
chronic pain or as an anti-platelet agent. Although some
preliminary evidence suggests that misoprostol, metro-
nidazole, and/or sulfasalazine have some effect in treating
NSAID-induced enteropathy, no confirmatory data exist.
In fact, one recent double-blind, randomized controlled
trial showed that neither metronidazole nor misoprostol
was able to significantly reduce the increased mucosal per-
meability secondary to indomethacin after one week [8].
Another similar study of rheumatoid arthritis patients
treated with NSAIDs found that sulfasalazine reduced
both intestinal inflammation and blood loss, while all
other disease-modifying antirheumatic drugs (DMARDs)
did not [9]. Furthermore, while selective COX-2 inhibitors
have been shown to decrease the rate of complications inding IBD, vasculitis, and vascular thrombi. The low power view
als necrotic debris intermixed with inflammatory cells (predominantly
, x200).
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agents are similarly effective in preventing NSAID-related
complications in the small bowel [10].
In the case described here, the patient received regular
twice-daily injections of diclofenac sodium for two
weeks. Similarly, the subsequent laboratory and histopath-
ologic findings were unable to identify any etiology for her
ileal perforations other than NSAID-induced gastropathy,
including inflammatory bowel disease, trauma, typhoid,
tuberculosis and amoebiasis. Accordingly, a diagnosis of
diclofenac sodium-induced multiple ileal perforation was
reached.
Conclusion
We report a unique case of multiple ileal perforations
due to regular diclofenac sodium injections and contend
that ileal perforation can be considered as a source for
pneumoperitoneum with concomitant peritonitis in pa-
tients with a history of NSAID use if other possibilities
are excluded.
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